ImageneBio (IMA) Total Current Liabilities (2020 - 2025)

ImageneBio has reported Total Current Liabilities for 6 years, with the latest figure at $11.2 million in Q4 2025.

• Quarterly Total Current Liabilities fell 34.72% year-over-year to $11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (down 34.72% YoY) and the FY2025 annual result came in at $11.2 million, down 34.72% from the prior year.
• Total Current Liabilities rose to $11.2 million in Q4 2025 per IMA's latest filing, from $11.1 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $30.6 million in Q3 2021 and troughed at $7.3 million in Q2 2025.
• A 5-year average of $18.1 million and a median of $15.7 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities sank 57.89% in 2023, then advanced 21.15% in 2024.
• Over 5 years, Total Current Liabilities stood at $27.2 million in 2021, then fell by 20.91% to $21.5 million in 2022, then slumped by 33.94% to $14.2 million in 2023, then increased by 21.15% to $17.2 million in 2024, then sank by 34.72% to $11.2 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $11.2 million, $11.1 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.